🇺🇸 FDA
Pipeline program

Bemnifosbuvir

AT-01B-004

Phase 2 small_molecule completed

Quick answer

Bemnifosbuvir for Chronic Hepatitis C Virus is a Phase 2 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Atea Pharmaceuticals
Indication
Chronic Hepatitis C Virus
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials